Search Result

Results for "

p 44

" in MCE Product Catalog:

By Targets:	Acyltransferase (2) Angiotensin Receptor (2) CDK (1) ERK (2) LPL Receptor (5) MAPKAPK2 (MK2) (1) Neuropeptide Y Receptor (2) NF-κB (1) Phosphodiesterase (PDE) (1) Small Interfering RNA (siRNA) (8) YAP (2)
By Research Areas:	Cancer (5) Cardiovascular Disease (3) Endocrinology (3) Infection (3) Metabolic Disease (2) Neurological Disease (7)
Oligonucleotides:	小干扰RNA (8) 小干扰RNA套装（小鼠） (4) 小干扰RNA套装（大鼠） (1) 小干扰RNA套装（人源） (3)

抑制剂 & 激动剂

天然产物

重组蛋白

抗体

寡核苷酸

没找到您心仪的产品？我们拥有更多针对信号通路的抑制剂、激动剂、调节剂

您还可以尝试以下方式，我们的专业人员为您服务

Cat. No.	Product Name	Target	Research Area	Chemical Structure

HY-N3806

Enniatin B	Acyltransferase ERK	Infection Cardiovascular Disease Cancer
恩镰孢菌素 B Enniatin B 是一种镰刀菌毒素。在大鼠肝微粒体酶实验中，Enniatin B 抑制酰基辅酶 A：胆固醇酰基转移酶 (ACAT) 活性，IC₅₀ 为 113 μM。Enniatins B 可降低 ERK (p44/p42) 活化。

HY-RS22569

Ifi44 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Ifi44 Mouse Pre-designed siRNA Set A 包括针对 Ifi44 (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

Ifi44 Mouse Pre-designed siRNA Set A Ifi44 Mouse Pre-designed siRNA Set A

HY-RS06556

IFI44 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
IFI44 Human Pre-designed siRNA Set A 包括针对 IFI44 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

IFI44 Human Pre-designed siRNA Set A IFI44 Human Pre-designed siRNA Set A

HY-RS20917

Eif3g Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Eif3g Mouse Pre-designed siRNA Set A 包括针对 Eif3g (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

Eif3g Mouse Pre-designed siRNA Set A Eif3g Mouse Pre-designed siRNA Set A

HY-RS05899

GTF2H2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
GTF2H2 Human Pre-designed siRNA Set A 包括针对 GTF2H2 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

GTF2H2 Human Pre-designed siRNA Set A GTF2H2 Human Pre-designed siRNA Set A

HY-RS15798

WDR77 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
WDR77 Human Pre-designed siRNA Set A 包括针对 WDR77 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

WDR77 Human Pre-designed siRNA Set A WDR77 Human Pre-designed siRNA Set A

HY-RS15102

Trp53 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Trp53 Mouse Pre-designed siRNA Set A 包括针对 Trp53 (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

Trp53 Mouse Pre-designed siRNA Set A Trp53 Mouse Pre-designed siRNA Set A

HY-RS08115

Mapk3 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Mapk3 Rat Pre-designed siRNA Set A 包括针对 Mapk3 (Rat) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

Mapk3 Rat Pre-designed siRNA Set A Mapk3 Rat Pre-designed siRNA Set A

HY-RS08114

Mapk3 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Mapk3 Mouse Pre-designed siRNA Set A 包括针对 Mapk3 (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

Mapk3 Mouse Pre-designed siRNA Set A Mapk3 Mouse Pre-designed siRNA Set A

HY-106477

Quazinone Ro 13-6438; Ro 13-6438/006	Phosphodiesterase (PDE) MAPKAPK2 (MK2)	Infection
Quazinone 是cGMP抑制磷酸二酯酶 (cGI-PDE, PDE3) 的选择性抑制剂。Quazinone 可抑制p42/p44 MAP激酶的磷酸化。Quazinone 具有抗微生物活性。

HY-N3807

Enniatin B1 1 篇文献验证	Acyltransferase ERK NF-κB	Infection Cardiovascular Disease Cancer
恩镰孢菌素 B1 Enniatin B1 是一种镰刀菌毒素。在大鼠肝微粒体酶实验中，Enniatin B1 抑制酰基辅酶 A：胆固醇酰基转移酶 (ACAT) 活性，IC₅₀ 为 73 μM。Enniatin B1 能透过血脑屏障。Enniatin B1 降低 ERK (p44/p42) 活化。Enniatin B1 抑制 TNF-α 诱导的 NF-κB激活。

HY-13285

Ki16425 最多引用文献 8 篇文献验证 Debio 0719	LPL Receptor YAP	Neurological Disease Cancer
Ki16425 (Debio 0719) 是一种亚型选择性，竞争性的 EDG 家族受体拮抗剂，对 LPA1 和 LPA3 的 K_i 值分别为 0.34 μM，0.93 μM。Ki16425 (Debio 0719) 降低 LPA 诱导的 p42/p44 MAPK 激活。Ki16425 还可抑制 LPA 诱导的 HEK293A 细胞中 YAP/TAZ 的去磷酸化。

HY-13106A

Olodanrigan sodium EMA401 sodium; PD-126055 sodium	Angiotensin Receptor	Neurological Disease Endocrinology
Olodanrigan (EMA401) sodium 是一个高选择性、口服活性、外周受限的血管紧张素 Ⅱ 类型 2 受体 (AT2R) 拮抗剂。Olodanrigan sodium 可用于神经性疼痛的研究。Olodanrigan sodium 的缓解疼痛作用似乎包括抑制增强的 AngII/AT2R 诱导的 p38 和 p42/p44 MAPK 激活，从而抑制 DRG 神经元的过度兴奋性和 DRG 神经元的萌发。

HY-13106

Olodanrigan 2 篇文献验证 EMA401; PD-126055; (S)-EMA400	Angiotensin Receptor	Cardiovascular Disease Neurological Disease Endocrinology
Olodanrigan (EMA401) 是一个高选择性、口服活性、外周受限的血管紧张素 Ⅱ 类型 2 受体 (AT2R) 拮抗剂。可用于神经性疼痛的研究。Olodanrigan (EMA401) 的缓解疼痛作用似乎包括抑制增强的 AngII/AT2R 诱导的 p38 和 p42/p44 MAPK 激活，从而抑制 DRG 神经元的过度兴奋性和 DRG 神经元的萌发。

HY-13285R

Ki16425 (Standard)	LPL Receptor YAP	Neurological Disease Cancer
Ki16425 (Standard）是 Ki16425 的分析标准品。本产品用于研究及分析应用。Ki16425 (Debio 0719) 是一种亚型选择性，竞争性的 EDG 家族受体拮抗剂，对 LPA1 和 LPA3 的 K_i 值分别为 0.34 μM，0.93 μM。Ki16425 (Debio 0719) 降低 LPA 诱导的 p42/p44 MAPK 激活。Ki16425 还可抑制 LPA 诱导的 HEK293A 细胞中 YAP/TAZ 的去磷酸化。

HY-W011428

Olomoucine	CDK	Others Cancer
Olomoucine 是 ATP 竞争性的 CDKs 的抑制剂。Olomoucine 是一种嘌呤 (HY-34431) 衍生物，可抑制 CDC2/cyclin B, Cdk2/cyclin a, Cdk2/cyclin E (IC₅₀=7 μM)，CDK/p35 激酶 (IC₅₀=3 μM) 和 ERK1/p44 MAPK 激酶的活性 (IC₅₀=25 μM)。Olomoucine 也具有调节细胞周期和抗黑色素肿瘤的能力。

HY-10968A

CYM5442 hydrochloride	LPL Receptor	Neurological Disease
CYM5442 hydrochloride 是一种有效的，高选择性和口服活性的鞘氨醇 1-磷酸 (S1P1) 受体激动剂，EC₅₀ 为 1.35 nM。CYM5442 hydrochloride 对 S1P2，S1P3，S1P4 和 S1P5 无活性。CYM5442 hydrochloride 激活依赖 S1P1 的 p42/p44-MAPK 磷酸化。CYM5442 hydrochloride 具有视网膜神经保护作用，并可轻松穿过中枢神经系统。

HY-10968

CYM5442 2 篇文献验证	LPL Receptor	Neurological Disease
CYM5442 是一种有效的，高选择性和口服活性的鞘氨醇 1-磷酸 (S1P1) 受体激动剂，EC₅₀ 为 1.35 nM。CYM5442 对 S1P2，S1P3，S1P4 和 S1P5 无活性。CYM5442 激活依赖 S1P1 的 p42/p44-MAPK 磷酸化。CYM5442 具有视网膜神经保护作用，并可轻松穿过中枢神经系统。

HY-10968R

CYM5442 (Standard)	LPL Receptor	Neurological Disease
CYM5442 (Standard）是 CYM5442 的分析标准品。本产品用于研究及分析应用。CYM5442 是一种有效的，高选择性和口服活性的鞘氨醇 1-磷酸 (S1P1) 受体激动剂，EC₅₀ 为 1.35 nM。CYM5442 对 S1P2，S1P3，S1P4 和 S1P5 无活性。CYM5442 激活依赖 S1P1 的 p42/p44-MAPK 磷酸化。CYM5442 具有视网膜神经保护作用，并可轻松穿过中枢神经系统。

HY-101986A

BIIE-0246 hydrochloride 1 篇文献验证 AR-H 053591 hydrochloride	Neuropeptide Y Receptor	Metabolic Disease
BIIE-0246 hydrochloride (AR-H 053591 hydrochloride) 是一种有效的选择性神经 Y 受体2 NPY2R 拮抗剂，对大鼠 [¹²⁵I]PYY_3-36 位点的 IC₅₀ 值为 15 nM。BIIE-0246 hydrochloride 在 NPY 刺激下降低 p-AKT S473、P-p44/42 MAPK 的表达。BIIE-0246 hydrochloride 减少 ADR 肾病患者的白蛋白尿。

HY-101986

BIIE-0246 1 篇文献验证 AR-H 053591	Neuropeptide Y Receptor	Metabolic Disease Endocrinology
BIIE-0246 (AR-H 053591) 是一种有效的选择性神经 Y 受体2 NPY2R 拮抗剂，对大鼠 [¹²⁵I]PYY_3-36 位点的 IC₅₀ 值为 15 nM。BIIE-0246 在 NPY 刺激下降低 p-AKT S473、P-p44/42 MAPK 的表达。BIIE-0246 减少 ADR 肾病患者的白蛋白尿。

Enniatin B	Infection Cardiovascular Disease Alkaloids Microorganisms Classification of Application Fields Source classification Disease Research Fields	Acyltransferase ERK
恩镰孢菌素 B Enniatin B 是一种镰刀菌毒素。在大鼠肝微粒体酶实验中，Enniatin B 抑制酰基辅酶 A：胆固醇酰基转移酶 (ACAT) 活性，IC₅₀ 为 113 μM。Enniatins B 可降低 ERK (p44/p42) 活化。

Enniatin B1 1 篇文献验证	Infection Cardiovascular Disease Alkaloids Structural Classification Microorganisms Classification of Application Fields Other Alkaloids Source classification Disease Research Fields	Acyltransferase ERK NF-κB
恩镰孢菌素 B1 Enniatin B1 是一种镰刀菌毒素。在大鼠肝微粒体酶实验中，Enniatin B1 抑制酰基辅酶 A：胆固醇酰基转移酶 (ACAT) 活性，IC₅₀ 为 73 μM。Enniatin B1 能透过血脑屏障。Enniatin B1 降低 ERK (p44/p42) 活化。Enniatin B1 抑制 TNF-α 诱导的 NF-κB激活。

Species:	Human (3)
Tag:	SUMO (2) His (2) GST (1)
Source:	E. coli (3)

Cat. No.	Compare	Product Name	Species	Source

HY-P701678

	ERK1 Protein, Human (GST) MAPK3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p44-ERK1	Human	E. coli
	ERK1 蛋白 ERK1蛋白是MAP激酶途径中重要的丝氨酸/苏氨酸激酶，与MAPK1/ERK2配合激活MAPK/ERK级联。在 KIT 和 KITLG/SCF 的刺激下，该通路在细胞生长、粘附、存活和分化中发挥着关键作用。ERK1 Protein, Human (GST) 是重组的 ERK1 蛋白，由 E. coli 表达，带有 N-GST 标签。

HY-P71622

	WDR77 Protein, Human (His-SUMO) 2610312E17Rik; Androgen receptor cofactor p44; C79984; HKMT1069; MEP 50; MEP-50; MEP50; Methylosome protein 50; WDR77	Human	E. coli
	WDR77 蛋白 WDR77 是与 PRMT5 和 CLNS1A 形成的甲基小体复合物的非催化成分，可调节剪接体 Sm 蛋白和组蛋白中的精氨酸至二甲基精氨酸。这种修饰将 Sm 蛋白引导至 SMN 复合物，帮助它们组装成小的核核糖核蛋白核心颗粒。WDR77 Protein, Human (His-SUMO) 是重组的 WDR77 蛋白，由 E. coli 表达，带有 N-His, N-SUMO 标签。

HY-P700506

	EIF3G Protein, Human (His-SUMO) eukaryotic translation initiation factor 3 subunit G; EIF3S4; EIF3-P42; eIF3-p44; eIF3-delta; eukaryotic translation initiation factor 3 subunit G; eukaryotic translation initiation factor 3 RNA-binding subunit; eukaryotic translation initiation factor 3 subunit p42; eukaryotic translation initiation factor 3, subunit 4 delta, 44kDa	Human	E. coli
	EIF3G 蛋白 EIF3G 蛋白是 eIF-3 复合物的 RNA 结合成分，通过促进因子的募集形成 43S PIC 来启动蛋白质合成。EIF3G 在 mRNA 募集和 AUG 识别扫描中都至关重要。EIF3G Protein, Human (His-SUMO) 是重组的 EIF3G 蛋白，由 E. coli 表达，带有 N-SUMO, N-6*His 标签。

产品对比


产品	In-stock - + Add to Cart
货号
种属
表达系统
标签
蛋白编号
基因 ID
分子量
纯度
内毒素含量
生物活性
性状
组分
保存条件 & 期限
运输条件
Free Sample	Yes No
规格	*该产品已“停产”。等效替代： / In-stock - + Add to Cart 询价

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80931

	WDR77 Antibody (YA655) WD repeat domain 77; p44; MEP50; MEP-50; HKMT1069; Nbla10071; p44/Mep50	WB, ICC/IF	Human, Mouse, Rat
	WDR77 Antibody (YA655) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to WDR77 (8A10). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

HY-P84237

	p44/42 MAPK (Erk1/2) Antibody (YA3934) ERK; p38; p40; p41; ERK2; ERT1; MAPK2; PRKM1; PRKM2; P42MAPK; p41mapk; MAPK1	WB, IHC-P, ICC/IF, FC, ELISA	Human, Mouse, Rabbit

HY-P86988

	*NK-p44* Antibody (YA6681)** Activating NK receptor NKp44 antibody; CD336 antibody; CD336 antigen antibody; dJ149M18.1 antibody; LY95 antibody; Lymphocyte antigen 95 (activating NK receptor NK p44) antibody; Lymphocyte antigen 95 homolog (activating NK receptor NK p44) antibody; Lymphocyte antigen 95 homolog antibody; Activating NK receptor NKp44 antibody; CD336 antibody; CD336 antigen antibody; dJ149M18.1 antibody; LY95 antibody; Lymphocyte antigen 95 (activating NK receptor NK p44) antibody; Lymphocyte antigen 95 homolog (activating NK receptor NK p44) antibody; Lymphocyte antigen 95 homolog antibody; Lymphocyte antigen 95, mouse, homolog of antibody; Natural cytotoxicity triggering receptor 2 antibody; Natural killer cell p44 related protein antibody; Natural killer cell p44-related protein antibody; NCR2 antibody; NCTR2_HUMAN antibody; NK cell activating receptor (NKp44) antibody; NK cell activating receptor antibody; NK cell-activating receptor antibody; NK p44 antibody; NK-p44 antibody; NKp44 antibody;	WB, IHC-P	Human, Mouse

HY-P85589

	WDR77 Antibody (YA5281) 2610312E17Rik; Androgen receptor cofactor p44; C79984; HKMT1069; MEP 50; MEP-50; MEP50; MEP50_HUMAN; Methylosome protein 50; MGC2722; Nbla10071; p44; p44/Mep50; RGD1310479; RP11 552M11.3; WD repeat containing protein 77; WD repeat domain 77; WD repeat-containing protein 77; WDR77.	WB, ICC	Human, Mouse, Rat

HY-P86387

	ERK 1/2 Antibody (YA6079) MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat,

HY-P86225

	Phospho-Erk 1/2(Thr202/Tyr204) Antibody (YA5917) MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p	WB, ICC/IF, IP, ELISA	Human, Mouse, Rat,

HY-P85839

	ERK 1 Antibody (YA5531) ERK1; ERT2; ERK-1; PRKM3; P44ERK1; P44MAPK; HS44KDAP; HUMKER1A; p44-ERK1; p44-MAPK	WB, ICC/IF, ELISA	Human, Mouse, Rat,

HY-P86654

	ERK1/2 Antibody (YA6346) ERK1+ERK2; ERK 1; ERK 2; ERK-2; ERK1; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK 3; MAPK1; MAPK2; MAPK3; MGC20180; Microtubule associated protein 2 kinase; Mitogen activated protein kinase 1; Mitogen activated protein kinase 2; Mitogen activated protein kinase 3; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 2; MK01_HUMAN; MK03_HUMAN; p38; p40; p41; p41mapk; p42 MAPK; p42-MAPK; p42MAPK; p44 ERK1; p44 MAPK; p44ERK1; p44MAPK; PRKM 1; PRKM 2; PRKM 3; PRKM1; PRKM2; PRKM3; Protein kinase mitogen activated 1; Protein kinase mitogen activated 2; Protein kinase mitogen activated 3; Protein tyrosine kinase ERK 2.	WB, IHC-P, IHC-F, ICC/IF, IF-Tissue, FC	Human, Mouse, Rat

HY-P85629

	*Phospho-p44/42 MAPK(Erk1/2)(Thr202/Tyr204) Antibody (YA5321)* ERK 1; ERK 2; ERK-2; ERK1; erk1/2; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK 3; MAPK 3; MAPK1; MAPK2; MAPK3; MGC20180; Microtubule associated protein 2 kinase; Mitogen activated protein kinase 1; Mitogen activated protein kinase 1; Mitogen activated protein kinase 2; Mitogen activated protein kinase 3; Mitogen activated protein kinase 3; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 2; MK01_HUMAN; p38; p40; p41; p41mapk; p42 MAPK; p42-MAPK; p42MAPK; p42MAPK; p44 ERK1; p44 MAPK; p44ERK1; p44ERK1; p44MAPK; p44MAPK; PRKM 1; PRKM 1; PRKM 2; PRKM 2; PRKM 3; PRKM 3; PRKM1; PRKM2; PRKM3; Protein kinase mitogen activated 1; Protein kinase mitogen activated 1; Protein kinase mitogen activated 2; Protein kinase mitogen activated 2; Protein kinase mitogen activated 3; Protein kinase mitogen activated 3; Protein tyrosine kinase ERK 2; Protein tyrosine kinase ERK 2.	WB	Human, Mouse

HY-P84224

	MAPK3 Antibody (YA3921) ERK1; PRKM3; P44ERK1; P44MAPK; HS44KDAP; HUMKER1A; MGC20180	WB, IHC-P, ICC/IF, FC, ELISA	Human, Mouse, Rat, Monkey

HY-P85893

	PSMD11 Antibody (YA5585) PSMD11; 26S proteasome non-ATPase regulatory subunit 11; 26S proteasome regulatory subunit RPN6; 26S proteasome regulatory subunit S9; 26S proteasome regulatory subunit p44.5	WB, ICC/IF, ELISA	Human, Mouse, Rat,